Press Releases

HOUSTON, Sept. 11, 2026 /PRNewswire/ -- Nabors Industries Ltd. (NYSE:NBR) invites you to join Anthony G. Petrello, Chairman, President and Chief Executive Officer, and Miguel A. Rodriguez, Chief Financial Officer, Wednesday October 28, 2026 at 10:00 a.m. Central Time for a discussion of operating results for the third quarter ended September 30, 2026.  Nabors will release earnings after the market closes on October 27, 2026.Date:October 28, 2026Time:10:00 a.m. CT (11:00 a.m. ET)Dial-in-number(s):US Toll Free:(888) 317-6003Canada Toll Free:(866) 284-3684International:(412) 317-6061Participant Elite Entry Number:3648722Please call ten to fifteen minutes ahead of time to ensure proper connectio

NEW YORK, Sept. 11, 2026 /PRNewswire/ -- Ares Dynamic Credit Allocation Fund, Inc. ("ARDC" or the "Fund") (NYSE:ARDC) announced today the declaration of its distribution for the month of September 2026 of $0.1125 per common share, payable as noted below.The following dates apply to the declared distribution:Ex-Date: September 21, 2026Record Date: September 21, 2026Payable Date: September 30, 2026Per Share Amount: $0.1125Based on the Fund's current share price of $12.17 (as of its close on September 10, 2026), the distribution represents an annualized distribution rate of approximately 11.09% (calculated by annualizing the distribution amount and dividing it by the current price). Information

The Amrize (NYSE:AMRZ) Board of Directors has appointed Mario Gross as President, Building Envelope, effective September 11, 2026. Gross succeeds Jake Gosa, who is stepping down from the role and is committed to a smooth transition. Gross has been a member of Amrize’s Executive Committee as its Chief Supply Chain Officer since the company’s listing on the NYSE in June 2025. He previously served as Chief Operating Officer of the Building Envelope business from 2024 to 2025, where he led operations to establish the segment as a leading provider of commercial and residential roofing, weatherproofing and insulation systems. Prior, Gross served in various commercial and operational roles of in

American Healthcare REIT, Inc. (NYSE:AHR) ("Company") announced today that Jeff Hanson, the Company’s Chairman and Chief Executive Officer, Gabe Willhite, the Company’s President and Chief Operating Officer, and Alan Peterson, the Company’s Vice President of Investor Relations & Finance, will participate in a roundtable presentation at BofA Securities Global Real Estate Conference on Tuesday, September 15, 2026, at 12:45 p.m. to 1:20 p.m. Eastern Time. A live webcast of the presentation will be available at the following link. A replay will be available at the same link following the completion of the conference on September 16, 2026 for up to one year.The Company will issue its investor pre

Essex Property Trust, Inc. (NYSE:ESS) announced today that Angela L. Kleiman, President and CEO, will be participating in a roundtable presentation at the 2026 Bank of America Global Real Estate Conference on Wednesday, September 16, 2026 at 10:20 a.m. Eastern Time. To listen to the panel, please visit the webcast link under the latest events section of the Company’s Investors website at www.essex.com. An archive of the webcast will be available for thirty days following the event. A copy of any materials provided by the Company at the conference can be obtained through the Investors section of the Company’s website. About Essex Property Trust, Inc. Essex Property Trust, Inc., an S&P

Blackstone Liquid Credit Strategies LLC, an affiliate of Blackstone Alternative Credit Advisors LP (collectively, and together with their affiliates in the credit-focused business of Blackstone, Inc., "Blackstone Credit & Insurance"), announced monthly distributions for the three listed closed-end funds it advises, Blackstone Senior Floating Rate 2027 Term Fund (NYSE:BSL), Blackstone Long-Short Credit Income Fund (NYSE:BGX), and Blackstone Strategic Credit 2027 Term Fund (NYSE:BGB) (each a "Fund" and together the "Funds"). The Funds’ monthly distributions are set forth below. The following dates apply to the distribution declarations for the Funds: Ticker Fund Monthly Dist

Holds 515,544 BNB tokens with a fair value of approximately $302.3 million at July 31, 2026Repurchased 1,434,112 shares of common stock for $3.8 million at an average price of $2.63 per shareReports first quarter fiscal 2027 net loss of $11.4 million, or $(0.22) per diluted share LOUISVILLE, CO, Sept. 11, 2026 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ:BNC) ("CEA Industries," "BNC," or the "Company"), a growth-oriented company focused on managing the world’s largest corporate treasury of BNB, today announced its financial results for the first quarter of fiscal 2027, ended July 31, 2026. First Quarter Fiscal 2027 Financial Highlights Net Loss: Reported a net loss of $11.4 million,

INDIANAPOLIS, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Kite Realty Group (NYSE:KRG) announced today that it will present at the BofA Securities 2026 Global Real Estate Conference. The presentation information is as follows: Event: Kite Realty Group Management PresentationWhen: September 15, 2026, at 3:00 p.m. ETLive Webcast: Kite Realty Group BofA Securities 2026 Global Real Estate ConferenceInvestor Presentation: KRG Q2 2026 Investor Update A replay of the webcast will be available at kiterealty.com following the completion of the conference. About Kite Realty Group Kite Realty Group (NYSE:KRG) is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of open-

DWS Municipal Income Trust (KTF) (the "Fund") announced today its regular September monthly distribution. Details are as follows: Declaration – 09/11/2026 Ex-Date – 09/23/2026 Record – 09/23/2026 Payable – 09/30/2026 Fund Ticker Distribution Per Share   Prior Distribution Per Share DWS Municipal Income Trust KTF $0.0610   $0.0610 The Fund intends to distribute all or substantially all of its net investment income each year through its regular monthly distributions and to distribute any realized capital gains at least annually. In addition, in any monthly period, to maintain its declared pe

Strata’s implementation platform includes provider training, certification, site readiness, and ongoing clinical support; its founders worked with Compass on the COMP360 training program for clinicians, who supported and monitored participants in Compass' clinical trials. Strata Mental Health Solutions, the expert-led training and implementation partner preparing clinical networks to deliver psychedelic treatments, today announced it has been awarded one of the five U.S. HCP training grants awarded by Compass Pathways (NASDAQ:CMPS) to develop U.S. health care provider training programs for COMP360, Compass’ investigational psilocybin treatment, if approved. Strata’s founders worked with C

SAN MATEO, Calif., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Oportun Financial Corporation ("Oportun", or the "Company") today announced that, on September 10, 2026, in accordance with the offer letter agreement with Sean Rowles, the Company's Chief Risk Officer, previously announced by the Company on June 16, 2026, it granted a long-term new hire equity award consisting of 382,653 restricted stock units representing the right to receive an equivalent number of shares of the Company's common stock ("RSUs") and 127,551 performance-vesting restricted stock units representing the right to receive an equivalent number of shares of the Company's common stock at target ("PSUs") to Mr. Rowles, effective

Antwerp, Belgium, September 11, 2026 – Agomab Therapeutics NV (NASDAQ:AGMB) ("Agomab" or the "Company"), a clinical-stage biopharmaceutical company focused on fibro-inflammatory diseases, today announced that shareholders approved all resolutions submitted for consideration at the Company's Special and Extraordinary General Shareholders' Meeting held on September 11, 2026. The approved resolutions included the appointments of Marino Garcia and Naimish Patel, M.D. as non-executive members of the Company's Board of Directors and the proposed consolidation and split adjustment of outstanding pre-Initial Public Offering (IPO) warrants. "We are grateful for the support of our shareholders and ex

EMERYVILLE, Calif., Sept. 11, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (NASDAQ:FDMT, 4DMT or the Company)), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on September 8, 2026, the compensation committee of the Company’s board of directors granted seven new non-executive employees 96,000 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company’s 2025 Employment Inducement Award Plan, as amended, under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter int

HOUSTON, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (the "Company") today announced that the Company's Board of Directors has approved a 1 for 12.62 reverse stock split of the Company's issued and outstanding common stock, par value $0.001 per share (the "Common Stock"). The reverse stock split will become effective at 12:01 a.m., Eastern Time, on September 23, 2026. Starting with the opening of trading on that date, the Company’s Common Stock will continue to trade on the NYSE American Exchange under the ticker symbol "IBO" and will trade under a new CUSIP number to be assigned in connection with the reverse stock split. On December 30, 2025, the Company's stockholders a

CAMBRIDGE, Mass., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (NASDAQ:KRRO), a biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA®) platform to develop a new class of genetic medicines for rare and highly prevalent diseases, today announced the grant of non-statutory stock options to three newly hired employees. Korro granted the new employees nonstatutory stock options to purchase 5,000 shares of Korro’s common stock, in the aggregate, at an exercise price of $12.93 per share, the closing price per share of Korro's common stock as reported by Nasdaq on the grant effective date, September 9, 2026. The options each have a ten-year ter

Delcath Systems, Inc. (NASDAQ:DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company’s Compensation Committee, as material inducements to four individuals whose employment commenced in either July 2026 or August 2026. The grants, in the form of Restricted Stock Units (RSUs), totaled 34,000 shares of the Company’s common stock and are subject to the terms and conditions of the Company’s 2023 Inducement Plan ("Plan"). The RSUs were granted on September 1, 2026 and one-third of the RSUs will vest on the first anniversary

Bentley Systems, Incorporated (NASDAQ:BSY) (the "Company"), the infrastructure engineering software company, today announced that its Board of Directors (the "Board") declared a $0.07 per share dividend for the third quarter of 2026. The cash dividend is payable on September 29, 2026, to all stockholders of record of Class A and Class B common stock as of the close of business on September 22, 2026. About Bentley Systems Around the world, infrastructure professionals rely on software from Bentley Systems to help them design, build, and operate better and more resilient infrastructure for transportation, water, energy, cities, and more. Founded in 1984 by engineers for engineers, Bentley i

NORWOOD, Mass., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), a clinical-stage company focused on developing new therapies in oncology and obesity, today announced that the Company’s management team will host a conference call webcast on Monday, September 14 at 8:00 a.m. EDT, to discuss topline data for CANYON-1, a Phase 1b study of CRB-913 for the treatment of obesity. Harold Bays, M.D., an investigator for the study, will be a guest speaker in the event. CRB-913 is a once-daily highly peripherally restricted oral CB1 inverse agonist potentially offering an orthogonal approach to weight loss and long-term weight management and a new therapeutic op

Ralph Lauren Corporation (NYSE:RL) announced that its Board of Directors has declared a regular quarterly dividend of $1.00 per share on Ralph Lauren Corporation Common Stock. The dividend is payable on October 9, 2026 to shareholders of record at the close of business on September 25, 2026. ABOUT RALPH LAUREN Ralph Lauren Corporation (NYSE:RL) is a global leader in the design, marketing and distribution of luxury lifestyle products in six categories: apparel, handbags, footwear & accessories, fragrances, home, and hospitality. For nearly 60 years, Ralph Lauren has sought to inspire the dream of a better life through authenticity and timeless style. Its reputation and distinctive image

MIAMI BEACH, Fla., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Herzfeld Credit Income Fund, Inc. (NASDAQ:HERZ) (the "Fund") today declared monthly distributions to stockholders of record as of the Record Dates set forth below for the months of October, November and December. Each monthly distribution will distribute to stockholders substantially all of the Fund’s net investment income and net short-term capital gains, as set forth in the Fund’s Prospectus.   The Fund has announced distributions of $0.17 per share for the months of October, November, and December, to be paid as follows: Monthly DistributionDeclaration DateEx-DateRecord DatePayment DatePer Share(estimated) October9/11/2610/23/2610/